A study to find out how long people with melanoma should have treatment with pembrolizumab and nivolumab (DANTE)
This study is for people with melanoma that has spread to other parts of the body (metastatic).
Stafford
Available
A trial looking at ixazomib for people with myeloma that has come back (Myeloma XII ACCoRd)
This is the first sentence of the introduction only, copied from the summary below. There should not be any links and it must be no longer than 160 characters
A study looking at everolimus in women being treated with hormone therapy for breast cancer (UNIRAD)
This study is looking to see if having a drug called everolimus alongside usual hormone therapy can reduce the risk of breast cancer coming back.
A trial looking at chemotherapy with or without bevacizumab for advanced ovarian cancer (ICON8B)
This trial is looking at chemotherapy with or without bevacizumab for advanced ovarian cancer, fallopian tube cancer or primary peritoneal carcinoma.
A trial looking at giving 1 week of radiotherapy for breast cancer (FAST-Forward)
This trial compared 1 week of radiotherapy with 3 weeks of radiotherapy after surgery for breast cancer.
A study to learn more about lung cancer in people who smoke (LungCAST)
This study is looking at whether smoking after diagnosis affects your outcome.
A study to find out why certain people develop oesophageal cancer (ChOPIN)
This study looked at whether genes affect the risk of developing oesophageal cancer
A trial comparing gemcitabine alone with gemcitabine and capecitabine together after surgery to remove cancer of the pancreas (ESPAC-4)
This trial is looking at gemcitabine on its own or alongside another drug called capecitabine after surgery for cancer of the pancreas.
A study looking at the genetic causes of bowel (colorectal) cancer (NSCCG)
This national study is trying to find out more about how a family history of the disease can increase people's risk of bowel cancer.
A trial to improve radiotherapy to treat cancer of the head and neck (ART DECO)
This trial compared standard dose radiotherapy with higher dose radiotherapy for people with certain types of head and neck cancer.